Education
About Us
Working with TipRanks
Follow Us
Dignitana AB (DIZTF)
:DIZTF
DIZTF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.13 - $0.23
Previous CloseN/A
Volume10.00
Average Volume (3M)0.00
Market Cap
$18.38M
Enterprise Value$170.21M
Total Cash (Recent Filing)$2.81M
Total Debt (Recent Filing)$6.86M
Price to Earnings (P/E)―
Beta0.15
Next Earnings
Nov 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding80,541,890
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap9.26
Enterprise Value/Revenue1.88
Enterprise Value/Gross Profit2.83
Enterprise Value/Ebitda-90.49
Forecast
1Y Price Target
$0.21Price Target Upside-4.55% Downside
Rating ConsensusHold
Number of Analyst Covering0
Dignitana AB News
DIZTF FAQ
What was Dignitana AB’s price range in the past 12 months?
Dignitana AB lowest stock price was $0.13 and its highest was $0.23 in the past 12 months.
What is Dignitana AB’s market cap?
Dignitana AB’s market cap is $18.38M.
When is Dignitana AB’s upcoming earnings report date?
Dignitana AB’s upcoming earnings report date is Nov 20, 2025 which is in 45 days.
How were Dignitana AB’s earnings last quarter?
Currently, no data Available
Is Dignitana AB overvalued?
According to Wall Street analysts Dignitana AB’s price is currently Overvalued.
Does Dignitana AB pay dividends?
Dignitana AB does not currently pay dividends.
What is Dignitana AB’s EPS estimate?
Dignitana AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dignitana AB have?
Dignitana AB has 80,541,890 shares outstanding.
What happened to Dignitana AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Dignitana AB?
Currently, no hedge funds are holding shares in DIZTF
Company Description
Dignitana AB
Dignitana AB (publ), a medical technology company, develops, produces, and markets medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. The company was incorporated in 2007 is headquartered in Lund, Sweden.